SCHEMBL5773513

SCHEMBL5773513

CCCc1nc(Cl)c2nc(-c3ccccc3)cc-2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.53
ADORA2A P29274 3/20 0.53
ADORA1 P30542 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.43
CTSK P43235 1/20 0.41
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 5/20 0.40
HPGD P15428 4/20 0.40
HSD17B10 Q99714 2/20 0.40
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
POLB P06746 1/20 0.38
PKM P14618 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
XDH P47989 1/20 0.37
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5773135 0.89 SMN1; SMN2 (0.55) ADORA3ADORA2AADORA1SMN1; SMN2ALDH1A1
SCHEMBL5774772 0.84 ADORA1 (0.53) ADORA3ADORA2AADORA1SMN1; SMN2CTSK
SCHEMBL5776325 0.83 ADORA1 (0.54) ADORA3ADORA2AADORA1SMN1; SMN2ALDH1A1
SCHEMBL5774543 0.79 ADORA1 (0.48) ADORA3ADORA2AADORA1SMN1; SMN2ALDH1A1
SCHEMBL5771482 0.78 KDM4E (0.47) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5776767 0.78 KDM4E (0.47) ADORA2AADORA1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL5774041 0.75 ADORA3 (0.51) ADORA3ADORA2AADORA1SMN1; SMN2ALDH1A1
SCHEMBL5773970 0.73 ADORA1 (0.49) ADORA3ADORA2AADORA1SMN1; SMN2ALDH1A1
SCHEMBL5771921 0.72 SMN1; SMN2 (0.55) ADORA3ADORA2AADORA1SMN1; SMN2ALDH1A1
SCHEMBL5772105 0.72 KDM4E (0.44) ADORA3ADORA2AADORA1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed